6533b831fe1ef96bd129974c

RESEARCH PRODUCT

Cellular cytotoxicity against the human hepatoma cell line PLC/PRF/5 in patients with hepatitis B virus-induced chronic active hepatitis (CAH) and non-A, non-B (NANB) CAH

K H Meyer Zum BüschenfeldeT. H. HütterothThomas Poralla

subject

Hepatitis B virusHepatitisHepatologybusiness.industryChronic Activemedicine.disease_causemedicine.diseaseVirologyPlc prf 5Hepatoma cell linemedicineIn patientCell-mediated cytotoxicitybusinesshttps://doi.org/10.1111/j.1600-0676.1982.tb00212.x